Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Neurobiol Dis. 2021 Jun 19;157:105428. doi: 10.1016/j.nbd.2021.105428

Table 2.

Relation of Epigenetic Clocks in Dorsolateral Prefrontal Cortex to Clinical Phenotypes

EPIGENETIC CLOCKS
Outcomes 1 Hannum Horvath PhenoAge GrimAge Cortical
CLINICAL DIAGNOSES Odds Ratio 2 per SD increase in clock age OR (95% CI)
Alzheimer’s Dementia 1.14 (0.93,1.41) 1.03 (0.83,1.29) 0.89 (0.74,1.07) 0.62 (0.39,0.98) 1.54 (1.14,2.08)
Any Dementia 1.13 (0.92,1.38) 1.00 (0.81,1.24) 0.93 (0.78,1.12) 0.61 (0.39, 0.96) 1.50 (1.12,2.02)
COGNITIVE DECLINE Mean difference in annual rate of decline per SD increase in clock age2
β (p-value)
Global cognition −0.001 (0.9) 0.007 (0.3) 0.004 (0.5) 0.036 (0.01) −0.03 (0.003)
Episodic memory −0.004 (0.6) 0.010 (0.2) 0.005 (0.4) 0.031 (0.06) −0.03 (0.02)
Semantic memory −0.004 (0.6) 0.008 (0.4) −0.002 (0.8) 0.041 (0.04) −0.03 (0.04)
Perceptual speed −0.002 (0.7) 0.007 (0.3) 0.002 (0.7) 0.027 (0.1) −0.03 (0.04)
Working memory 0.002 (0.7) 0.004 (0.5) 0.002 (0.7) 0.041 (0.01) −0.03 (0.004)
Visuospatial ability −0.004 (0.5) −0.002 (0.7) −0.002 (0.8) 0.026 (0.07) −0.03 (0.003)
OTHER NEUROLOGIC PHENOTYPES
Parkinsonian signs 0.003 (0.7) −0.004 (0.7) −0.003 (0.7) −0.017 (0.4) 0.03 (0.05)
Motor function 0.001 (0.4) 0.002 (0.4) 0.001 (0.6) 0.003 (0.5) −0.001 (0.7)
GENETIC FACTORS Odds Ratio 2 per SD increase in clock age
OR (95% CI)
ApoE e4 genotype (e3e4/e4e4) 1.13 (0.90, 1.42) 1.12 (0.88, 1.43) 1.11 (0.90, 1.36) 1.02 (0.62,1.70) 1.49 (1.06,2.09)
1

For Horvath, Hannum, PhenoAge, GrimAge clocks n=680 for global cognition, episodic memory, semantic memory, working memory; n=661 for perceptual speed and visuospatial ability; n=677 for Parkinsonian signs; n=635 for motor function; n=702 for Alzheimer’s dementia and 721 for dementia; n=697 for apoE. For Cortical clock we further excluded 88 participants who had been part of the original training set for the Cortical clock.

2

Odds ratios (OR) and mean differences adjusted for age at death, sex, education, and baseline levels of depressive symptoms